GHRP-2

Also known as: Pralmorelin, Growth hormone releasing peptide-2, KP-102

Limited Evidence

Classification

Peptide

Regulatory Status

not-established

Overview

GHRP-2 (pralmorelin) is a synthetic hexapeptide ghrelin-receptor agonist that stimulates pituitary growth hormone release and has been studied as a diagnostic secretagogue.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

Pathways

GH-IGF-1 axisghrelin signalingghrelin receptor agonismGH secretion stimulationghrelin receptor (GHSR)

Interactions & cautions

Flagged in source data

CJC-1295 or other GH secretagogues without clinical rationale

Drug interactions

other GH secretagogues or GHRH analogs — Overlapping pharmacology and safety burden. (review)

These are observational flags for review, not individualized instructions.

Sources

https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks (opens in a new tab)
https://pubmed.ncbi.nlm.nih.gov/17609397/ (opens in a new tab)
https://pubchem.ncbi.nlm.nih.gov/compound/5493556 (opens in a new tab)

Educational reference only — not medical advice.